A randomized phase III study optimizing adjuvant osimertinib for resected EGFR-mutant stage II-III non-squamous non-small cell lung cancer: OASIS trial (JACTOP-01).
Ken Onodera
Yoshinori Okada
Y. Kudo
M. Yotsukura
Keisuke Asakura
Yasushi Goto
Satoshi Shiono
S. Toyooka
Y. Maniwa
T. Chen-Yoshikawa
Shun-ichi Watanabe
M. Taguri
Nodoka Seya
T. Mizutani
H. Kunitoh
Norihiko Ikeda
Medicine